Annual report pursuant to Section 13 and 15(d)

Note T - Subsequent Events

v3.19.1
Note T - Subsequent Events
12 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Subsequent Events [Text Block]
NOTE T — SUBSEQUENT EVENTS
 
In
February 2019,
Milestone Scientific consummated a public offering and a private placement of Common Stock. The public offering generated gross proceeds of approximately
$2.0
million for the issuance of
5,715,000
shares of common stock and warrants to purchase
1,428,000
shares of common stock. The warrants term is
5
 years and they are exercisable at
$.50.
Subsequent to the public offering the underwriter exercised its overallotment option and paid approximately
$198,000
for  
567,400
additional shares.
 
Also, in
February 2019,
the Company generated gross proceeds from a private placement of approximately
$250,000
for
714,286
shares of common stock and warrants to purchase
178,594
shares of common stock from  
Bp4
 S.p.A., a principal stockholder of Milestone Scientific, that exercised its right to participate on a pro-rata basis on the recent public offering.
Bp4’s
CEO is a director of Milestone Scientific and also Chief Executive Officer and Director of Wand Dental, a wholly owned subsidiary of Milestone Scientific.
 
 
F-
25